Sarah Carmody | Executive Director, IR & Corporate Communications |
Anna Protopapas | President, CEO & Director |
Brian DeSchuytner | SVP, Finance & Product Strategy |
Timothy Lowinger | Chief Science & Technology Officer |
Arvin Yang | SVP & Chief Medical Officer |
Jonathan Chang | SVB Leerink |
Kaveri Pohlman | BTIG |
Boris Peaker | Cowen and Company |
Jessica Fye | JPMorgan Chase & Co. |
Benjamin Paluch | Robert W. Baird & Co. |
Good morning, and welcome to Mersana Therapeutics Second Quarter 2021 Conference Call and Webcast. [Operator Instructions]. I'd now like to turn the call over to Sarah Carmody, Executive Director, Investor Relations and Corporate Communications. Please proceed.
Good morning.